Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
1993-5-27
pubmed:abstractText
The detection of antibody to the hepatitis C virus C100-3 antigen from the nonstructural region (NS3/NS4) of the viral genome was the first useful marker developed to detect past or potentially active infection with the hepatitis C virus. A systematic epitope survey of the nonstructural region has uncovered other immunogenic antigens. In order to assess the possible diagnostic utility of these antigens, their reactivity against a limited panel of sera from patients with chronic liver disease due to hepatitis C virus and other etiologies was tested. Antibody assays were performed using an immunoblot plaque assay and an enzyme-linked immunosorbent assay (ELISA). In a study of 16 C100-3-reactive individuals, all 16 patients were reactive using the plaque assay for the NS3 3' (409-1-1) and NS3 5' (C33u). In this same group of patients, antibodies by ELISA were reactive to NS3 3' in 12 of 16 patients (75%), NS3 5' in 15 of 16 patients (93%), and a capsid antigen (NC450) in 14 of 16 patients. In a group of five patients who were diagnosed with cryptogenic liver disease (C100-3 negative), 4 of 5 patients were reactive for antibody to all of the above epitopes. In a survey of 23 patients with other forms of chronic liver disease (nonviral liver disease, hepatitis B, alcoholic liver disease, cholestatic liver disease, and autoimmune hepatitis), only 1 of 23 patients was reactive for antibody to the C100-3 and 4 of 23 patients were reactive for antibodies to structural and nonstructural regions of the virus.(ABSTRACT TRUNCATED AT 250 WORDS)
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
0882-8245
pubmed:author
pubmed:issnType
Print
pubmed:volume
6
pubmed:owner
NLM
pubmed:authorsComplete
N
pubmed:pagination
49-54
pubmed:dateRevised
2011-11-17
pubmed:meshHeading
pubmed-meshheading:7682814-Acute Disease, pubmed-meshheading:7682814-Adult, pubmed-meshheading:7682814-Amino Acid Sequence, pubmed-meshheading:7682814-Antigens, Viral, pubmed-meshheading:7682814-Base Sequence, pubmed-meshheading:7682814-Biological Markers, pubmed-meshheading:7682814-Capsid, pubmed-meshheading:7682814-Child, pubmed-meshheading:7682814-Enzyme-Linked Immunosorbent Assay, pubmed-meshheading:7682814-Epitopes, pubmed-meshheading:7682814-Female, pubmed-meshheading:7682814-Hepacivirus, pubmed-meshheading:7682814-Hepatitis Antibodies, pubmed-meshheading:7682814-Hepatitis C, pubmed-meshheading:7682814-Hepatitis C Antibodies, pubmed-meshheading:7682814-Humans, pubmed-meshheading:7682814-Immunoblotting, pubmed-meshheading:7682814-Liver Diseases, pubmed-meshheading:7682814-Male, pubmed-meshheading:7682814-Molecular Sequence Data, pubmed-meshheading:7682814-Polymerase Chain Reaction, pubmed-meshheading:7682814-Sexual Partners, pubmed-meshheading:7682814-Viral Nonstructural Proteins, pubmed-meshheading:7682814-Viral Plaque Assay
pubmed:year
1993
pubmed:articleTitle
Variation in antibody reactivity to the hepatitis C virus by comparative immunoscreening and enzyme immunoassay.
pubmed:affiliation
California Pacific Medical Center, San Francisco.
pubmed:publicationType
Journal Article, Comparative Study